Increased Cholinergic Response in α-Synuclein Transgenic Mice (h-α-synL62)

Magdalena König, Beata Berlin, Karima Schwab, Silke Frahm, Franz Theuring, Claude M Wischik, Charles R Harrington, Gernot Riedel, Jochen Klein

Research output: Contribution to journalArticle

Abstract

Pathological accumulation of misfolded α-synuclein (α-syn) in the brain plays a key role in the pathogenesis of Parkinson's disease, leading to neuronal dysfunction and motor disorders. The underlying mechanisms linking α-syn aggregations with neurotransmitter disturbance in Parkinson's brains are not well characterized. In the present study, we investigated transgenic mice expressing an aggregation-prone form of full-length human α-syn (h-α-synL62) linked to a signal sequence. These mice display dopamine depletion and progressive motor deficits. We detected accumulation of α-syn in cholinergic interneurons where they are colocalized with choline acetyltransferase. Using microdialysis, we measured acetylcholine levels in the striatum at baseline and during stimulation in the open field and with scopolamine. While no difference between wild-type and transgenic mice was detected in 3 month old mice, striatal acetylcholine levels at 9 months of age were significantly higher in transgenic mice. Concomitantly, high-affinity choline uptake was also increased while choline acetyltransferase and acetylcholine esterase activities were unchanged. The results suggest a disinhibition of acetylcholine release in α-syn transgenic mice.

Original languageEnglish
Pages (from-to)1915-1922
Number of pages8
JournalACS Chemical Neuroscience
Volume10
Issue number4
Early online date28 Sep 2018
DOIs
Publication statusPublished - 2019

Fingerprint

Synucleins
Cholinergic Agents
Transgenic Mice
Acetylcholine
Choline O-Acetyltransferase
Brain
Agglomeration
Corpus Striatum
Scopolamine Hydrobromide
Microdialysis
Interneurons
Esterases
Protein Sorting Signals
Choline
Neurotransmitter Agents
Parkinson Disease
Dopamine

Keywords

  • alpha-synuclein
  • acetylcholine
  • microdialysis
  • cholinergic interneurons
  • scopolamine
  • muscarinic receptors
  • BASAL GANGLIA
  • HIPPOCAMPAL ACETYLCHOLINE-RELEASE
  • MEDIATED MODULATION
  • IN-VIVO
  • DOPAMINE
  • NEURONS
  • Alpha-synuclein
  • ACETYLTRANSFERASE
  • INTERNEURONS
  • BRAIN
  • PARKINSONS-DISEASE

Cite this

Increased Cholinergic Response in α-Synuclein Transgenic Mice (h-α-synL62). / König, Magdalena; Berlin, Beata; Schwab, Karima; Frahm, Silke; Theuring, Franz; Wischik, Claude M; Harrington, Charles R; Riedel, Gernot; Klein, Jochen.

In: ACS Chemical Neuroscience, Vol. 10, No. 4, 2019, p. 1915-1922.

Research output: Contribution to journalArticle

König, Magdalena ; Berlin, Beata ; Schwab, Karima ; Frahm, Silke ; Theuring, Franz ; Wischik, Claude M ; Harrington, Charles R ; Riedel, Gernot ; Klein, Jochen. / Increased Cholinergic Response in α-Synuclein Transgenic Mice (h-α-synL62). In: ACS Chemical Neuroscience. 2019 ; Vol. 10, No. 4. pp. 1915-1922.
@article{e5180aba4f504bbaa04044f34ed38a37,
title = "Increased Cholinergic Response in α-Synuclein Transgenic Mice (h-α-synL62)",
abstract = "Pathological accumulation of misfolded α-synuclein (α-syn) in the brain plays a key role in the pathogenesis of Parkinson's disease, leading to neuronal dysfunction and motor disorders. The underlying mechanisms linking α-syn aggregations with neurotransmitter disturbance in Parkinson's brains are not well characterized. In the present study, we investigated transgenic mice expressing an aggregation-prone form of full-length human α-syn (h-α-synL62) linked to a signal sequence. These mice display dopamine depletion and progressive motor deficits. We detected accumulation of α-syn in cholinergic interneurons where they are colocalized with choline acetyltransferase. Using microdialysis, we measured acetylcholine levels in the striatum at baseline and during stimulation in the open field and with scopolamine. While no difference between wild-type and transgenic mice was detected in 3 month old mice, striatal acetylcholine levels at 9 months of age were significantly higher in transgenic mice. Concomitantly, high-affinity choline uptake was also increased while choline acetyltransferase and acetylcholine esterase activities were unchanged. The results suggest a disinhibition of acetylcholine release in α-syn transgenic mice.",
keywords = "alpha-synuclein, acetylcholine, microdialysis, cholinergic interneurons, scopolamine, muscarinic receptors, BASAL GANGLIA, HIPPOCAMPAL ACETYLCHOLINE-RELEASE, MEDIATED MODULATION, IN-VIVO, DOPAMINE, NEURONS, Alpha-synuclein, ACETYLTRANSFERASE, INTERNEURONS, BRAIN, PARKINSONS-DISEASE",
author = "Magdalena K{\"o}nig and Beata Berlin and Karima Schwab and Silke Frahm and Franz Theuring and Wischik, {Claude M} and Harrington, {Charles R} and Gernot Riedel and Jochen Klein",
year = "2019",
doi = "10.1021/acschemneuro.8b00274",
language = "English",
volume = "10",
pages = "1915--1922",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "AMER CHEMICAL SOC",
number = "4",

}

TY - JOUR

T1 - Increased Cholinergic Response in α-Synuclein Transgenic Mice (h-α-synL62)

AU - König, Magdalena

AU - Berlin, Beata

AU - Schwab, Karima

AU - Frahm, Silke

AU - Theuring, Franz

AU - Wischik, Claude M

AU - Harrington, Charles R

AU - Riedel, Gernot

AU - Klein, Jochen

PY - 2019

Y1 - 2019

N2 - Pathological accumulation of misfolded α-synuclein (α-syn) in the brain plays a key role in the pathogenesis of Parkinson's disease, leading to neuronal dysfunction and motor disorders. The underlying mechanisms linking α-syn aggregations with neurotransmitter disturbance in Parkinson's brains are not well characterized. In the present study, we investigated transgenic mice expressing an aggregation-prone form of full-length human α-syn (h-α-synL62) linked to a signal sequence. These mice display dopamine depletion and progressive motor deficits. We detected accumulation of α-syn in cholinergic interneurons where they are colocalized with choline acetyltransferase. Using microdialysis, we measured acetylcholine levels in the striatum at baseline and during stimulation in the open field and with scopolamine. While no difference between wild-type and transgenic mice was detected in 3 month old mice, striatal acetylcholine levels at 9 months of age were significantly higher in transgenic mice. Concomitantly, high-affinity choline uptake was also increased while choline acetyltransferase and acetylcholine esterase activities were unchanged. The results suggest a disinhibition of acetylcholine release in α-syn transgenic mice.

AB - Pathological accumulation of misfolded α-synuclein (α-syn) in the brain plays a key role in the pathogenesis of Parkinson's disease, leading to neuronal dysfunction and motor disorders. The underlying mechanisms linking α-syn aggregations with neurotransmitter disturbance in Parkinson's brains are not well characterized. In the present study, we investigated transgenic mice expressing an aggregation-prone form of full-length human α-syn (h-α-synL62) linked to a signal sequence. These mice display dopamine depletion and progressive motor deficits. We detected accumulation of α-syn in cholinergic interneurons where they are colocalized with choline acetyltransferase. Using microdialysis, we measured acetylcholine levels in the striatum at baseline and during stimulation in the open field and with scopolamine. While no difference between wild-type and transgenic mice was detected in 3 month old mice, striatal acetylcholine levels at 9 months of age were significantly higher in transgenic mice. Concomitantly, high-affinity choline uptake was also increased while choline acetyltransferase and acetylcholine esterase activities were unchanged. The results suggest a disinhibition of acetylcholine release in α-syn transgenic mice.

KW - alpha-synuclein

KW - acetylcholine

KW - microdialysis

KW - cholinergic interneurons

KW - scopolamine

KW - muscarinic receptors

KW - BASAL GANGLIA

KW - HIPPOCAMPAL ACETYLCHOLINE-RELEASE

KW - MEDIATED MODULATION

KW - IN-VIVO

KW - DOPAMINE

KW - NEURONS

KW - Alpha-synuclein

KW - ACETYLTRANSFERASE

KW - INTERNEURONS

KW - BRAIN

KW - PARKINSONS-DISEASE

UR - http://www.mendeley.com/research/increased-cholinergic-response-%CE%B1synuclein-transgenic-mice-h%CE%B1synl62-1

U2 - 10.1021/acschemneuro.8b00274

DO - 10.1021/acschemneuro.8b00274

M3 - Article

VL - 10

SP - 1915

EP - 1922

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 4

ER -